These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 1657382)

  • 21. Cell line identification.
    Ferrone S; Pellegrino MA; Cooper NR
    Science; 1976 Oct; 194(4264):480. PubMed ID: 17783651
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of Gelatinases MMP-2 and MMP-9 in Healthy and Complicated Pregnancy and Their Future Potential as Preeclampsia Biomarkers.
    Nikolov A; Popovski N
    Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33803206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A glimpse of matrix metalloproteinases in diabetic nephropathy.
    Xu X; Xiao L; Xiao P; Yang S; Chen G; Liu F; Kanwar YS; Sun L
    Curr Med Chem; 2014; 21(28):3244-60. PubMed ID: 25039784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiology and pathophysiology of matrix metalloproteases.
    Klein T; Bischoff R
    Amino Acids; 2011 Jul; 41(2):271-90. PubMed ID: 20640864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).
    Teicher BA
    Cancer Metastasis Rev; 1996 Jun; 15(2):247-72. PubMed ID: 8842498
    [No Abstract]   [Full Text] [Related]  

  • 26. Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo.
    Sawaya RE; Yamamoto M; Gokaslan ZL; Wang SW; Mohanam S; Fuller GN; McCutcheon IE; Stetler-Stevenson WG; Nicolson GL; Rao JS
    Clin Exp Metastasis; 1996 Jan; 14(1):35-42. PubMed ID: 8521615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.
    Teicher BA; Sotomayor EA; Huang ZD; Ara G; Holden S; Khandekar V; Chen YN
    Cancer Chemother Pharmacol; 1993; 33(3):229-38. PubMed ID: 8269604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.
    Brown PD; Levy AT; Margulies IM; Liotta LA; Stetler-Stevenson WG
    Cancer Res; 1990 Oct; 50(19):6184-91. PubMed ID: 2169338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells.
    Lauricella-Lefebvre MA; Castronovo V; Sato H; Seiki M; French DL; Merville MP
    Invasion Metastasis; 1993; 13(6):289-300. PubMed ID: 7860222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Inr-containing sequence flanking the TATA box of the human c-sis (PDGF-B) proto-oncogene promoter functions in cis as a co-activator for its intronic enhancer.
    Franklin GC; Adam GI; Miller SJ; Moncrieff CL; Ullerås E; Ohlsson R
    Oncogene; 1995 Nov; 11(9):1873-84. PubMed ID: 7478617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells.
    Frisch SM; Reich R; Collier IE; Genrich LT; Martin G; Goldberg GI
    Oncogene; 1990 Jan; 5(1):75-83. PubMed ID: 2157183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and expression of type IV collagenase genes.
    Tryggvason K; Huhtala P; Tuuttila A; Chow L; Keski-Oja J; Lohi J
    Cell Differ Dev; 1990 Dec; 32(3):307-12. PubMed ID: 1965956
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of a basal promoter for the human Mr 72,000 type IV collagenase gene and enhanced expression in a highly metastatic cell line.
    Templeton NS; Stetler-Stevenson WG
    Cancer Res; 1991 Nov; 51(22):6190-3. PubMed ID: 1657382
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.